Morphology of Vaccine RD&D translation

Translation as a concept coordinates participation in innovation but remains a qualitative construct. We provide multivariate accounting of linkages between market entries of vaccines, clinical trials, patents, publications, funders, and grants to quantify biomedical translation. We found that the m...

Full description

Saved in:
Bibliographic Details
Published in:arXiv.org 2023-10
Main Authors: Ho, Martin, Henry CW Price, Evans, Tim S, O'Sullivan, Eoin
Format: Article
Language:English
Subjects:
Product development
Translations
Vaccines
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Translation as a concept coordinates participation in innovation but remains a qualitative construct. We provide multivariate accounting of linkages between market entries of vaccines, clinical trials, patents, publications, funders, and grants to quantify biomedical translation. We found that the most prevalent types of biomedical translation are those between basic and applied research (52 percent) followed by those between research and product development (36 percent). Although many biomedical stakeholders assume knowledge flows one way from upstream research to downstream application, knowledge feedbacks that mediate translation are prevalent. We also cluster biomedical funders based on the types of translations they fund. Large-scale funding agencies such as NIH are similarly involved in early-stage translation, whereas pharmaceuticals and mission-oriented agencies such as DARPA involve diverse translation types, and each leaves different translation footprints.
ISSN:2331-8422